In rTg4510 mice that model AD tau pathology,[28] Lyzl4 expression levels showed a significant increase at 4, 6, and 8 months compared to their WT counterparts (Figure S1B, Supporting Information), suggesting that Lyzl4 might be a genetic factor contributing to the progression of AD. The gene discussed is MAPT; the disease is Alzheimer disease.